These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31138864)
1. Role of deleterious single nucleotide variants in the coding regions of TNFAIP3 for Japanese autoimmune hepatitis with cirrhosis. Higuchi T; Oka S; Furukawa H; Nakamura M; Komori A; Abiru S; Hashimoto S; Shimada M; Yoshizawa K; Kouno H; Naganuma A; Ario K; Kaneyoshi T; Yamashita H; Takahashi H; Makita F; Yatsuhashi H; Ohira H; Migita K Sci Rep; 2019 May; 9(1):7925. PubMed ID: 31138864 [TBL] [Abstract][Full Text] [Related]
2. rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population. Xu E; Cao H; Lin L; Liu H PLoS One; 2017; 12(4):e0176471. PubMed ID: 28448618 [TBL] [Abstract][Full Text] [Related]
3. Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population. Oka S; Higuchi T; Furukawa H; Nakamura M; Komori A; Abiru S; Nagaoka S; Hashimoto S; Naganuma A; Naeshiro N; Yoshizawa K; Shimada M; Nishimura H; Tomizawa M; Kikuchi M; Makita F; Yamashita H; Ario K; Yatsuhashi H; Tohma S; Kawasaki A; Tsuchiya N; Migita K J Hum Genet; 2018 Jun; 63(6):739-744. PubMed ID: 29559739 [TBL] [Abstract][Full Text] [Related]
4. TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients. Ciccacci C; Latini A; Perricone C; Conigliaro P; Colafrancesco S; Ceccarelli F; Priori R; Conti F; Perricone R; Novelli G; Borgiani P J Immunol Res; 2019; 2019():6728694. PubMed ID: 31534975 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between the CARD10 rs6000782 polymorphism and type 1 autoimmune hepatitis in a Japanese population. Migita K; Jiuchi Y; Furukawa H; Nakamura M; Komori A; Yasunami M; Kozuru H; Abiru S; Yamasaki K; Nagaoka S; Hashimoto S; Bekki S; Yoshizawa K; Shimada M; Kouno H; Kamitsukasa H; Komatsu T; Hijioka T; Nakamuta M; Naganuma A; Yamashita H; Nishimura H; Ohta H; Nakamura Y; Ario K; Oohara Y; Sugi K; Tomizawa M; Sato T; Takahashi H; Muro T; Makita F; Mita E; Sakai H; Yatsuhashi H BMC Res Notes; 2015 Dec; 8():777. PubMed ID: 26652023 [TBL] [Abstract][Full Text] [Related]
6. Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response. Higuchi T; Oka S; Furukawa H; Tohma S; Yatsuhashi H; Migita K Hum Genomics; 2021 Jan; 15(1):6. PubMed ID: 33509297 [TBL] [Abstract][Full Text] [Related]
7. Genetic background of autoimmune hepatitis in Japan. Yoshizawa K; Umemura T; Ota M J Gastroenterol; 2011 Jan; 46 Suppl 1():42-7. PubMed ID: 20957499 [TBL] [Abstract][Full Text] [Related]
8. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk. Kim T; Bae SC; Kang C Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614 [TBL] [Abstract][Full Text] [Related]
9. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Fortes Mdel P; Machado IV; Gil G; Fernández-Mestre M; Dagher L; León RV; Bianco NE; Tassinari P Liver Int; 2007 Dec; 27(10):1409-16. PubMed ID: 17927716 [TBL] [Abstract][Full Text] [Related]
10. HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype. Oka S; Furukawa H; Yasunami M; Kawasaki A; Nakamura H; Nakamura M; Komori A; Abiru S; Nagaoka S; Hashimoto S; Naganuma A; Naeshiro N; Yoshizawa K; Yamashita H; Ario K; Ohta H; Sakai H; Yabuuchi I; Takahashi A; Abe K; Yatsuhashi H; Tohma S; Ohira H; Tsuchiya N; Migita K PLoS One; 2017; 12(10):e0187325. PubMed ID: 29088299 [TBL] [Abstract][Full Text] [Related]
11. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study. Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Medrano LM; Aldámiz-Echevarria T; Pérez-Latorre L; Díez C; Martín-Vicente M; Gutiérrez-Rivas M; Martínez I; Resino S Infect Genet Evol; 2019 Jan; 67():112-120. PubMed ID: 30336268 [TBL] [Abstract][Full Text] [Related]
12. Association of TNF-α-308 Polymorphism with Susceptibility to Autoimmune Hepatitis in Tunisians. Chaouali M; Azaiez MB; Tezeghdenti A; Lagha A; Yacoubi-Oueslati B; Ghazouani E; Abdallah HB; Kochkar R Biochem Genet; 2018 Dec; 56(6):650-662. PubMed ID: 29845365 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. de Boer YS; van Gerven NM; Zwiers A; Verwer BJ; van Hoek B; van Erpecum KJ; Beuers U; van Buuren HR; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Kraal G; Mulder CJ; van Nieuwkerk CM; Fischer J; Berg T; Stickel F; Sarrazin C; Schramm C; Lohse AW; Weiler-Normann C; Lerch MM; Nauck M; Völzke H; Homuth G; Bloemena E; Verspaget HW; Kumar V; Zhernakova A; Wijmenga C; Franke L; Bouma G; ; ; Gastroenterology; 2014 Aug; 147(2):443-52.e5. PubMed ID: 24768677 [TBL] [Abstract][Full Text] [Related]
14. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. Bittencourt PL; Farias AQ; Porta G; Cançado EL; Miura I; Pugliese R; Kalil J; Goldberg AC; Carrilho FJ J Clin Gastroenterol; 2008 Mar; 42(3):300-5. PubMed ID: 18223493 [TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1 alleles of susceptibility and protection in Iranians with autoimmune hepatitis. Baharlou R; Faghihi-Kashani A; Faraji F; Najafi-Samei M; Setareh M; Zamani F; Tajik N Hum Immunol; 2016 Apr; 77(4):330-5. PubMed ID: 26780502 [TBL] [Abstract][Full Text] [Related]
16. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Agarwal K; Czaja AJ; Donaldson PT Tissue Antigens; 2007 Mar; 69(3):227-35. PubMed ID: 17493146 [TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Bittencourt PL; Goldberg AC; Cançado EL; Porta G; Carrilho FJ; Farias AQ; Palacios SA; Chiarella JM; Abrantes-Lemos CP; Baggio VL; Laudanna AA; Kalil J Am J Gastroenterol; 1999 Jul; 94(7):1906-13. PubMed ID: 10406258 [TBL] [Abstract][Full Text] [Related]
18. Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan. Umemura T; Joshita S; Yamazaki T; Komatsu M; Katsuyama Y; Yoshizawa K; Tanaka E; Ota M Sci Rep; 2016 Jul; 6():29770. PubMed ID: 27406031 [TBL] [Abstract][Full Text] [Related]
19. Fas polymorphisms influence susceptibility to autoimmune hepatitis. Hiraide A; Imazeki F; Yokosuka O; Kanda T; Kojima H; Fukai K; Suzuki Y; Hata A; Saisho H Am J Gastroenterol; 2005 Jun; 100(6):1322-9. PubMed ID: 15929764 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between FCRL3 and FcgammaRII polymorphisms in Japanese type 1 autoimmune hepatitis. Umemura T; Ota M; Yoshizawa K; Katsuyama Y; Ichijo T; Tanaka E; Kawa S; Kiyosawa K Clin Immunol; 2007 Mar; 122(3):338-42. PubMed ID: 17020818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]